Bariatric surgery is known to have profound effects on type 2 diabetes mellitus, yet only a fraction of eligible patients will be considered for this type of intervention. In the UK, eligibility criteria for surgery are becoming increasingly strict and diabetes has emerged as the most important comorbid indication for surgery in the obese patient. This review examines current evidence for bariatric surgery in obese diabetic patients with a view to raising the profile of this life changing intervention.
DayCBaileyCJ. Obesity in the pathogenesis of type 2 diabetes. Br J Diabetes Vasc Dis2011;11:55-61.
6.
PoriesWJSwansonMSMacDonaldKG. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg1995;222:339-50;discussion 350-2.
7.
RubinoFForgioneACummingsDE. The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes. Ann Surg2006;244:741-749.
AshrafianHle RouxCWRowlandSP. Metabolic surgery and obstructive sleep apnoea:the protective effects of bariatric procedures. Thorax2012;67:442-9.
10.
AshrafianHBueterMAhmedK. Metabolic surgery:an evolution through bariatric animal models. Obes Rev2010;11:907-20
11.
AshrafianHAthanasiouT. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypassObes Rev2011;12:257-72.
12.
BuchwaldHEstokRFahrbachK. Weight and type 2 diabetes after bariatric surgery:systematic review and meta-analysis. Am J Med2009;122:248-256.e5.
13.
DormanRBSerrotFJMillerCJ. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg2012;255:287-93.
14.
DixonJBO’BrienPPlayfairJ. Adjustable gastric banding and conventional therapy for type 2 diabetes:a randomized controlled trial. JAMA2008;299:316-23.
15.
ChikunguwoSMWolfeLGDodsonP. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis2010;6:254-9.
16.
KaderaBELumKGrantJ. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis2009;5:305-9.
17.
BlackstoneRBuntJCCortésMCSugermanHJ. Type 2 diabetes after gastric bypass:remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis2012May18. (Epub ahead of print).
18.
PicotJJonesJColquittJL. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity:a systematic review and economic evaluation. Health Technol Assess2009;13: 1-190, 215-357.
19.
KleinSGhoshACremieuxPY. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m2. Obesity (Silver Spring)2011;19:581-7.
20.
CremieuxPYBuchwaldHShikoraSA. A study on the economic impact of bariatric surgery. Am J Manag Care2008;14:589-96.
21.
TiceJAKarlinerLWalshJ. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med2008;121:885-93.
22.
DeMariaEJPortenierDWolfeL. Obesity surgery mortality risk score:proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surgery for Obesity and Related Diseases 32007;3:134-140.
23.
DeMariaEJMurrMByrneK. Validation of the Obesity Surgery Mortality Risk Score in a Multicenter Study Proves It Stratifies Mortality Risk in Patients Undergoing Gastric Bypass for Morbid Obesity. Ann Surg2007;246:578–584.
24.
EfthimiouECourtOSampalisJChristouN. Validation of Obesity Surgery Mortality Risk Score in patients undergoing gastric bypass in a Canadian center. Surgery for Obesity and Related Diseases 52009;5:643-647.
25.
ShimizuHTimratanaPSchauerPRRogulaT. Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI<35kg/m(2). J Obes2012;2012:147256. (Epub 2012 Jun 5).
